Lenalidomide hydrochloride
Lenalidomide hydrochloride
 Lenalidomide hydrochloride |
|
A3547-50 |
ApexBio |
50 mg |
EUR 154 |
|
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
Lenalidomide hydrochloride |
|
A3547-500 |
ApexBio |
500 mg |
EUR 258 |
|
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
) Lenalidomide-C4-NH2 (hydrochloride) |
|
HY-115446A |
MedChemExpress |
500mg |
EUR 1714 |
 Lenalidomide |
|
20-abx076543 |
Abbexa |
|
|
- Shipped within 5-12 working days.
|
Lenalidomide |
|
L044-100MG |
TOKU-E |
100 mg |
EUR 178 |
Lenalidomide |
|
L044-25MG |
TOKU-E |
25 mg |
EUR 78 |
 Lenalidomide hemihydrate |
|
B1188-100 |
ApexBio |
100 mg |
EUR 122 |
|
Description: Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. |
-Lenalidomide) (R,S)-Lenalidomide |
|
1862-100 |
Biovision |
|
EUR 245 |
) Lenalidomide (CC-5013) |
|
A4211-100 |
ApexBio |
100 mg |
EUR 189 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-250 |
ApexBio |
250 mg |
EUR 224 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-50 |
ApexBio |
50 mg |
EUR 154 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-500 |
ApexBio |
500 mg |
EUR 258 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-S |
ApexBio |
Evaluation Sample |
EUR 81 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
-Lenalidomide) EZSolution? (R,S)-Lenalidomide |
|
B1503-10 |
Biovision |
|
EUR 120 |
) Lenalidomide (Ubiquitin ligase inducer) |
|
SIH-410-10MG |
Stressmarq |
10 mg |
EUR 149 |
- Clinically, lenalidomide has proven to be effective in the treatment of multiple myeloma and other B cell diseases. It has the ability to selectively bind and ubiquitinate two lymphoid transcription factors, IKZF1 and IKZF2, via the CRBN-CRL4 ubiquit
- Show more
|
|
Description: The substance Lenalidomide is a ubiquitin ligase inducer. It is synthetically produced and has a purity of >98%. The pure substance is powder which is soluble in DMSO (200 mM), Water (<1 mM) and Ethanol (<1 mM).. |
Lenalidomide (Ubiquitin ligase inducer) |
|
SIH-410-50MG |
Stressmarq |
50 mg |
EUR 317 |
- Clinically, lenalidomide has proven to be effective in the treatment of multiple myeloma and other B cell diseases. It has the ability to selectively bind and ubiquitinate two lymphoid transcription factors, IKZF1 and IKZF2, via the CRBN-CRL4 ubiquit
- Show more
|
|
Description: The substance Lenalidomide is a ubiquitin ligase inducer. It is synthetically produced and has a purity of >98%. The pure substance is powder which is soluble in DMSO (200 mM), Water (<1 mM) and Ethanol (<1 mM).. |
 TAME Hydrochloride |
|
2050-100 |
Biovision |
|
EUR 126 |
TAME Hydrochloride |
|
2050-1000 |
Biovision |
|
EUR 479 |
TAME Hydrochloride |
|
2050-500 |
Biovision |
|
EUR 338 |
 Verapamil hydrochloride |
|
2861-1G |
Biovision |
|
EUR 131 |
Verapamil hydrochloride |
|
2861-5G |
Biovision |
|
EUR 327 |
 Ticlopidine hydrochloride |
|
2919-25 |
Biovision |
|
EUR 403 |
Ticlopidine hydrochloride |
|
2919-5 |
Biovision |
|
EUR 153 |
 AdipoRon hydrochloride |
|
2572-25 |
Biovision |
|
EUR 588 |
AdipoRon hydrochloride |
|
2572-5 |
Biovision |
|
EUR 185 |
 Pargyline hydrochloride |
|
2618-1000 |
Biovision |
|
EUR 175 |
Pargyline hydrochloride |
|
2618-500 |
Biovision |
|
EUR 120 |
 Clorgyline hydrochloride |
|
2622-10 |
Biovision |
|
EUR 120 |
Clorgyline hydrochloride |
|
2622-50 |
Biovision |
|
EUR 327 |
 Clindamycin hydrochloride |
|
2627-10 |
Biovision |
|
EUR 131 |
Clindamycin hydrochloride |
|
2627-50 |
Biovision |
|
EUR 370 |
 Loperamide hydrochloride |
|
2683-1000 |
Biovision |
|
EUR 185 |
Loperamide hydrochloride |
|
2683-500 |
Biovision |
|
EUR 131 |
 Clonidine hydrochloride |
|
2684-100 |
Biovision |
|
EUR 131 |
Clonidine hydrochloride |
|
2684-500 |
Biovision |
|
EUR 359 |
 Leelamine hydrochloride |
|
2717-25 |
Biovision |
|
EUR 457 |
Leelamine hydrochloride |
|
2717-5 |
Biovision |
|
EUR 153 |
 SBE13 hydrochloride |
|
2847-10 |
Biovision |
|
EUR 185 |
SBE13 hydrochloride |
|
2847-50 |
Biovision |
|
EUR 588 |
 Amodiaquine hydrochloride |
|
A085-5G |
TOKU-E |
5 g |
EUR 55 |
 Metformin, Hydrochloride |
|
1691-5G |
Biovision |
|
EUR 158 |
 Irinotecan Hydrochloride |
|
1752-250 |
Biovision |
|
EUR 387 |
Irinotecan Hydrochloride |
|
1752-50 |
Biovision |
|
EUR 147 |
 Epirubicin Hydrochloride |
|
1753-25 |
Biovision |
|
EUR 457 |
Epirubicin Hydrochloride |
|
1753-5 |
Biovision |
|
EUR 158 |
 Gemcitabine Hydrochloride |
|
1759-100 |
Biovision |
|
EUR 370 |
Gemcitabine Hydrochloride |
|
1759-25 |
Biovision |
|
EUR 156 |
 Amiodarone Hydrochloride |
|
1828-100 |
Biovision |
|
EUR 126 |
Amiodarone Hydrochloride |
|
1828-500 |
Biovision |
|
EUR 338 |
 Phenformin hydrochloride |
|
1889-100 |
Biovision |
|
EUR 115 |
Phenformin hydrochloride |
|
1889-1000 |
Biovision |
|
EUR 359 |
 Tomatidine hydrochloride |
|
1893-25 |
Biovision |
|
EUR 137 |
Lenalidomide hydrochloride
)
)
